Signaling pathways and mesenchymal transition in pediatric high-grade glioma
暂无分享,去创建一个
[1] L. Cerchia,et al. PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas , 2019, Cancers.
[2] T. Peterson,et al. Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells , 2019, PloS one.
[3] Adré Marshall. Invasion , 2018, Best "New" African Poets 2018 Anthology.
[4] J. Koster,et al. Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies , 2017, Experimental cell research.
[5] K. Ligon,et al. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] M. Ruge,et al. Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. , 2017, Journal of neurosurgery. Pediatrics.
[7] E. Sánchez,et al. External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry , 2017, Journal of Neuro-Oncology.
[8] Meng Li,et al. Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. , 2017, Cancer cell.
[9] C. Kramm,et al. Snail homolog 1 is involved in epithelial-mesenchymal transition-like processes in human glioblastoma cells. , 2017, Oncology letters.
[10] Rachel N. Rattenni,et al. Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas. , 2017, The American journal of pathology.
[11] S. Yamada,et al. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma. , 2017, International Journal of Oncology.
[12] K. Carraway,et al. Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination , 2017, Oncogene.
[13] F. Di Meco,et al. Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells. , 2017, Cancer research.
[14] Ning Liu,et al. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth , 2016, Cell.
[15] S. Pfister,et al. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner , 2016, Oncotarget.
[16] A. Jimeno,et al. Emerging from their burrow: Hedgehog pathway inhibitors for cancer , 2016, Expert opinion on investigational drugs.
[17] Jon R. Wilson,et al. Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2 , 2016, Nature Communications.
[18] Keith L. Ligon,et al. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma , 2016, Nature Communications.
[19] I. Nakano,et al. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans , 2016, Oncogene.
[20] D. Brat,et al. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. , 2016, Neuro-oncology.
[21] A. Sica,et al. Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies , 2016, Oncogene.
[22] M. Hegi,et al. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1 , 2016, Oncogene.
[23] Kun Xu,et al. Retraction Note to: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma , 2015, Molecular Neurobiology.
[24] Y. Suh,et al. Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. , 2015, Pathology, research and practice.
[25] Kun Xu,et al. RETRACTED ARTICLE: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma , 2015, Molecular Neurobiology.
[26] C. Eberhart,et al. ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres , 2015, Brain pathology.
[27] S. Babashah,et al. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer. , 2015, European journal of cancer.
[28] C. Eberhart,et al. Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition , 2015, Journal of neuropathology and experimental neurology.
[29] A. Truong,et al. Targeted Therapy for MAPK Alterations in Pediatric Gliomas , 2015, Brain disorders & therapy.
[30] T. Ay,et al. Targeted Therapy for MAPK Alterations in Pediatric Gliomas. , 2015 .
[31] M. Nykter,et al. Twist predicts poor outcome of patients with astrocytic glioma , 2015, Journal of Clinical Pathology.
[32] M. Millward,et al. Secreted Frizzled-Related Protein 4 Inhibits Glioma Stem-Like Cells by Reversing Epithelial to Mesenchymal Transition, Inducing Apoptosis and Decreasing Cancer Stem Cell Properties , 2015, PloS one.
[33] Ki-Chun Yoo,et al. Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer , 2015, Cancer science.
[34] Y. Xiong,et al. The 14-3-3σ/GSK3β/β-catenin/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer , 2015, Oncotarget.
[35] G. Pilkington,et al. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells , 2015, Oncotarget.
[36] H. Mehdorn,et al. Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1 , 2015, Oncotarget.
[37] Zhaoming Li,et al. Six1 promotes glioblastoma cell proliferation and invasion by upregulation of connective tissue growth factor. , 2015, American journal of cancer research.
[38] Xuqi Li,et al. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer , 2015, Tumor Biology.
[39] Bino John,et al. Genome-Wide Transcript Profiling Reveals Novel Breast Cancer-Associated Intronic Sense RNAs , 2015, PloS one.
[40] A. Moon,et al. Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H‐Ras‐induced epithelial to mesenchymal transition , 2015, International journal of cancer.
[41] Jun Du,et al. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells , 2015, Oncotarget.
[42] H. Huber,et al. Axl activates autocrine transforming growth factor‐β signaling in hepatocellular carcinoma , 2015, Hepatology.
[43] S. Ren,et al. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients. , 2015, International journal of clinical and experimental pathology.
[44] R. Reis,et al. AXL as a modulator of sunitinib response in glioblastoma cell lines. , 2015, Experimental cell research.
[45] E. Choi,et al. Compromised MAPK signaling in human diseases: an update , 2015, Archives of Toxicology.
[46] Michael A. Durante,et al. Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation , 2015, Oncogene.
[47] Ming-hua Bai,et al. Silencing of HIF-1α enhances the radiation sensitivity of human glioma growth in vitro and in vivo , 2015, Neuropharmacology.
[48] Ziwei Wang,et al. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway. , 2015, Cancer letters.
[49] C. Sze,et al. Modulation of Sonic hedgehog signaling and WW domain containing oxidoreductase WOX1 expression enhances radiosensitivity of human glioblastoma cells , 2015, Experimental biology and medicine.
[50] Q. Shi,et al. Β-catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition. , 2015, Biochemical and biophysical research communications.
[51] H. Duffau,et al. Notch1 Stimulation Induces a Vascularization Switch With Pericyte‐Like Cell Differentiation of Glioblastoma Stem Cells , 2015, Stem cells.
[52] David T. W. Jones,et al. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma , 2014, Acta neuropathologica communications.
[53] C. Allis,et al. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation , 2014, Science.
[54] G. Maira,et al. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment , 2014, Molecular Cancer.
[55] Young Yang,et al. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling. , 2014, Cancer letters.
[56] Ying-jian Liang,et al. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling , 2014, BMC Cancer.
[57] Gabriele Schackert,et al. Molecular characterization of long‐term survivors of glioblastoma using genome‐ and transcriptome‐wide profiling , 2014, International journal of cancer.
[58] David T. W. Jones,et al. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. , 2014, Neuro-oncology.
[59] Chris Jones,et al. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma , 2014, Nature Reviews Cancer.
[60] Janfeng Wang,et al. The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma. , 2014, International journal of clinical and experimental pathology.
[61] Jun Du,et al. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells , 2014, Cell and Tissue Research.
[62] Hae-Yun Jung,et al. Molecular Pathways: Linking Tumor Microenvironment to Epithelial–Mesenchymal Transition in Metastasis , 2014, Clinical Cancer Research.
[63] I. Mackenzie,et al. The receptor tyrosine kinase Axl regulates cell–cell adhesion and stemness in cutaneous squamous cell carcinoma , 2014, Oncogene.
[64] A. Bullock,et al. Structure–Activity Relationship of 3,5-Diaryl-2-aminopyridine ALK2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants , 2014, Journal of medicinal chemistry.
[65] B. Bonavida,et al. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention , 2014, Journal of experimental & clinical cancer research : CR.
[66] E. Llamosas,et al. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. , 2014, Gynecologic oncology.
[67] L. Norton,et al. N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties , 2014, Oncogene.
[68] Peng Zhang,et al. Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway , 2014, The Journal of pathology.
[69] K. Creek,et al. Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes. , 2014, Carcinogenesis.
[70] Joseph Rosenbluh,et al. KRAS and YAP1 Converge to Regulate EMT and Tumor Survival , 2014, Cell.
[71] P. Malatesta,et al. A cadherin switch underlies malignancy in high-grade gliomas , 2014, Oncogene.
[72] Jianping Zhang,et al. HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT , 2014, Tumor Biology.
[73] Yizhi Liu,et al. The Complex Interplay between ERK1/2, TGFβ/Smad, and Jagged/Notch Signaling Pathways in the Regulation of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelium Cells , 2014, PloS one.
[74] X. Chen,et al. Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells. , 2014, Current molecular medicine.
[75] H. Shirato,et al. Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. , 2014, Neuro-oncology.
[76] K. Jeong,et al. A ROS/STAT3/HIF‐1α signaling cascade mediates EGF‐induced TWIST1 expression and prostate cancer cell invasion , 2014, The Prostate.
[77] X. Chen,et al. Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer , 2014, Cell Death and Disease.
[78] Stephen Yip,et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma , 2014, Nature Genetics.
[79] Liliana Goumnerova,et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma , 2014, Nature Genetics.
[80] Amar Gajjar,et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma , 2014, Nature Genetics.
[81] Y. Jeng,et al. Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma. , 2014, Carcinogenesis.
[82] C. Kang,et al. A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo. , 2014, Oncology reports.
[83] K. Arita,et al. Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining , 2014, Brain Tumor Pathology.
[84] B. Wang,et al. Overexpression of integrin-linked kinase (ILK) promotes glioma cell invasion and migration and down-regulates E-cadherin via the NF-κB pathway , 2014, Journal of Molecular Histology.
[85] B. Zhou,et al. Epigenetic regulation of EMT: the Snail story. , 2014, Current pharmaceutical design.
[86] Michael Brudno,et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations , 2014, Nature Genetics.
[87] A. Pierce,et al. MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme , 2014, Oncotarget.
[88] Samy Lamouille,et al. Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.
[89] E. Aronica,et al. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation. , 2014, Neuro-oncology.
[90] Zhaoming Li,et al. Targeting Six1 by lentivirus-mediated RNA interference inhibits colorectal cancer cell growth and invasion. , 2014, International journal of clinical and experimental pathology.
[91] I. Kim,et al. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases , 2014, BMC Cancer.
[92] M. Millward,et al. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells. , 2014, Oncology research.
[93] Hao Wang,et al. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway. , 2014, European journal of pharmacology.
[94] J. Vadgama,et al. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits , 2013, International journal of oncology.
[95] L. Miele,et al. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. , 2013, Cancer letters.
[96] H. Hermeking,et al. SNAIL and miR‐34a feed‐forward regulation of ZNF281/ZBP99 promotes epithelial–mesenchymal transition , 2013, The EMBO journal.
[97] B. Zhou,et al. The Role of Snail in EMT and Tumorigenesis. , 2013, Current cancer drug targets.
[98] M. Salto‐Tellez,et al. AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer , 2013, Clinical Cancer Research.
[99] Jing Zhang,et al. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells , 2013, BMC Cancer.
[100] D. McDonald,et al. Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia , 2013, Oncogene.
[101] J. Shao,et al. Suppressing the malignant phenotypes of glioma cells by lentiviral delivery of small hairpin RNA targeting hypoxia-inducible factor-1α. , 2013, International journal of clinical and experimental pathology.
[102] T. Ryken,et al. NOTCH3 Is a Prognostic Factor That Promotes Glioma Cell Proliferation, Migration and Invasion via Activation of CCND1 and EGFR , 2013, PloS one.
[103] H. Ford,et al. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. , 2013, Cancer research.
[104] Yong Li,et al. Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance , 2013, Cell Death and Disease.
[105] Y. Kudo,et al. The FGFR1 inhibitor PD173074 induces mesenchymal–epithelial transition through the transcription factor AP-1 , 2013, British Journal of Cancer.
[106] Chen Huang,et al. Hypoxia-Induced Snail Expression Through Transcriptional Regulation by HIF-1α in Pancreatic Cancer Cells , 2013, Digestive Diseases and Sciences.
[107] T. Tan,et al. EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway , 2013, PloS one.
[108] Miles A. Miller,et al. The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells , 2013, Science Signaling.
[109] D. Steindler,et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance , 2013, EMBO molecular medicine.
[110] Mahlon D. Johnson,et al. Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes. , 2013, Cell reports.
[111] T. Merchant,et al. Children's Oncology Group's 2013 blueprint for research: Central nervous system tumors , 2013, Pediatric blood & cancer.
[112] S. Shankar,et al. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. , 2013, Neuro-oncology.
[113] B. Garcia,et al. Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.
[114] H. Poulsen,et al. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures , 2013, Cancer biology & therapy.
[115] Yongmei Song,et al. The Expressions of Wnt/β-catenin Pathway-Related Components in Brainstem Gliomas , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[116] A. Shiras,et al. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma , 2013, Molecular and Cellular Neuroscience.
[117] Qi Zhang,et al. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. , 2013, Carcinogenesis.
[118] Ziwei Wang,et al. Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-β, and E-cadherin expression in gastric carcinoma , 2013, Contemporary oncology.
[119] G. Basso,et al. Wnt activation promotes neuronal differentiation of Glioblastoma , 2013, Cell Death and Disease.
[120] C. Heldin,et al. Snail depletes the tumorigenic potential of glioblastoma , 2013, Oncogene.
[121] D. Radisky,et al. AXL induces epithelial to mesenchymal transition and regulates the function of breast cancer stem cells , 2013, Oncogene.
[122] Y. Chen,et al. Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells , 2013, Neurological Sciences.
[123] Ge Zhang,et al. Epithelial–Mesenchymal Transition (EMT) Induced by TNF-α Requires AKT/GSK-3β-Mediated Stabilization of Snail in Colorectal Cancer , 2013, PloS one.
[124] Gareth Browne,et al. ZEB/miR‐200 feedback loop: At the crossroads of signal transduction in cancer , 2013, International journal of cancer.
[125] A. Merlo,et al. Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme , 2013, Oncogene.
[126] Yongmei Song,et al. Expression of β-catenin and E- and N-cadherin in human brainstem gliomas and clinicopathological correlations , 2013, The International journal of neuroscience.
[127] G. Basso,et al. Wnt activation promotes neuronal differentiation of Glioblastoma , 2013, Cell Death and Disease.
[128] Xiao-ming Meng,et al. Role of the TGF-β/BMP-7/Smad pathways in renal diseases. , 2013, Clinical science.
[129] Y. Shang,et al. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. , 2013, Experimental cell research.
[130] Miqin Zhang,et al. Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β‐catenin , 2013, The journal of gene medicine.
[131] G. Nikkhah,et al. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. , 2012, Cancer letters.
[132] Jin Zeng,et al. PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. , 2012, Cellular signalling.
[133] J. Inazawa,et al. SIX1 promotes epithelial–mesenchymal transition in colorectal cancer through ZEB1 activation , 2012, Oncogene.
[134] C. Gondi,et al. Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathway. , 2012, Cellular signalling.
[135] Michael Peyton,et al. An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance , 2012, Clinical Cancer Research.
[136] David T. W. Jones,et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.
[137] D. Zagzag,et al. Mechanisms of glioma-associated neovascularization. , 2012, The American journal of pathology.
[138] S. Weiss,et al. Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression , 2012, Proceedings of the National Academy of Sciences.
[139] A. Pierce,et al. Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology , 2012, Oncogene.
[140] J. Casal,et al. Akt2 interacts with Snail1 in the E-cadherin promoter , 2012, Oncogene.
[141] R. Ballotti,et al. The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion , 2012, PloS one.
[142] H. Ford,et al. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways , 2012, Breast Cancer Research.
[143] Hao Wang,et al. ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma , 2012, PloS one.
[144] Jae Cheol Lee,et al. Activation of the AXL Kinase Causes Resistance to EGFR-Targeted Therapy in Lung Cancer , 2012, Nature Genetics.
[145] David T. W. Jones,et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas , 2012, Acta Neuropathologica.
[146] Chi Wang,et al. Interaction with Suv39H1 is Critical for Snail-mediated E-cadherin Repression in Breast Cancer , 2012, Oncogene.
[147] S. Kohsaka,et al. STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression , 2012, Molecular Cancer Therapeutics.
[148] L. Macconaill,et al. Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma , 2012, Pediatric blood & cancer.
[149] Weiling Zhao,et al. ERK/GSK3β/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. , 2012, Free radical biology & medicine.
[150] Do-Hyun Nam,et al. Wnt activation is implicated in glioblastoma radioresistance , 2012, Laboratory Investigation.
[151] C. Rüegg,et al. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. , 2012, Cancer discovery.
[152] P. Varlet,et al. Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas , 2012, PloS one.
[153] L. Tran,et al. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. , 2012, Cancer research.
[154] J. Blenis,et al. Down-regulation of CMTM8 Induces Epithelial-to-Mesenchymal Transition-like Changes via c-MET/Extracellular Signal-regulated Kinase (ERK) Signaling* , 2012, The Journal of Biological Chemistry.
[155] E. Kondo,et al. Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway , 2012, British Journal of Cancer.
[156] Tao Chen,et al. Notch1 promotes glioma cell migration and invasion by stimulating β‐catenin and NF‐κB signaling via AKT activation , 2012, Cancer science.
[157] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[158] Li Ding,et al. Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.
[159] Yun Cui,et al. Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition* , 2011, The Journal of Biological Chemistry.
[160] A. Rustgi,et al. Constitutive K-RasG12D Activation of ERK2 Specifically Regulates 3D Invasion of Human Pancreatic Cancer Cells via MMP-1 , 2011, Molecular Cancer Research.
[161] D. Dinh,et al. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1 , 2011, Oncotarget.
[162] J. Huse,et al. Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas. , 2011, Cancer research.
[163] S. Oh,et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. , 2011, Cancer research.
[164] T. Jiang,et al. Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways. , 2011, Oncology reports.
[165] Barbara S. Paugh,et al. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[166] S. Shirasawa,et al. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study , 2011, Molecular Cancer.
[167] K. Nan,et al. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. , 2011, International journal of oncology.
[168] M. Mimeault,et al. Complex Oncogenic Signaling Networks Regulate Brain Tumor‐Initiating Cells and Their Progenies: Pivotal Roles of Wild‐Type EGFR, EGFRvIII Mutant and Hedgehog Cascades and Novel Multitargeted Therapies , 2011, Brain pathology.
[169] P. Yue,et al. Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells , 2011, Oncogene.
[170] Hideo Nakamura,et al. Essential role of the Hedgehog signaling pathway in human glioma‐initiating cells , 2011, Cancer science.
[171] D. He,et al. Knockdown of β-Catenin Through shRNA Cause a Reversal of EMT and Metastatic Phenotypes Induced by HIF-1α , 2011, Cancer investigation.
[172] A. Satelli,et al. Vimentin in cancer and its potential as a molecular target for cancer therapy , 2011, Cellular and Molecular Life Sciences.
[173] Jun Qin,et al. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. , 2011, Cancer research.
[174] Kai Huang,et al. High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. , 2011, Neuro-oncology.
[175] Xiaodong Jin,et al. Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations , 2011, Clinical and Experimental Medicine.
[176] Hongwei Zhang,et al. miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3 , 2011, Molecular Cancer Research.
[177] Lei Wang,et al. β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells , 2011, Medical oncology.
[178] J. Kim,et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas , 2011, Oncogene.
[179] C. Miracco,et al. β-catenin and Gli1 are prognostic markers in glioblastoma , 2011, Cancer biology & therapy.
[180] J. Mpindi,et al. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer , 2011, Oncogene.
[181] Wei Li,et al. Notch1 expression is upregulated in glioma and is associated with tumor progression , 2011, Journal of Clinical Neuroscience.
[182] I. Weissman,et al. Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma , 2011, Proceedings of the National Academy of Sciences.
[183] K. Arita,et al. Wnt‐5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP‐2 , 2011, Cancer science.
[184] R. Jope,et al. The role of DDX3 in regulating Snail. , 2011, Biochimica et biophysica acta.
[185] Y. Minami,et al. Critical role of Wnt5a–Ror2 signaling in motility and invasiveness of carcinoma cells following Snail‐mediated epithelial–mesenchymal transition , 2011, Genes to cells : devoted to molecular & cellular mechanisms.
[186] Fang Gao,et al. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells , 2011, BMC Cancer.
[187] U. Cortes,et al. STAT3 is essential for the maintenance of neurosphere‐initiating tumor cells in patients with glioblastomas: A potential for targeted therapy? , 2011, International journal of cancer.
[188] M. Post,et al. Mouse Snail Is a Target Gene for HIF , 2011, Molecular Cancer Research.
[189] Sik Yoon,et al. SNAI1 is Involved in the Proliferation and Migration of Glioblastoma Cells , 2011, Cellular and Molecular Neurobiology.
[190] Tao Jiang,et al. Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription , 2010, Brain Research.
[191] Luigi Marchionni,et al. The Notch Target Hes1 Directly Modulates Gli1 Expression and Hedgehog Signaling: A Potential Mechanism of Therapeutic Resistance , 2010, Clinical Cancer Research.
[192] M. Bjørås,et al. Mitochondrial DNA Integrity Is Essential For Mitochondrial Maturation During Differentiation of Neural Stem Cells , 2010, Stem cells.
[193] H. Lo. Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. , 2010, Current cancer drug targets.
[194] C. Cohen,et al. Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis , 2010, BMC nephrology.
[195] S. Aaronson,et al. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. , 2010, Genes & development.
[196] S. Chi,et al. Activated STAT3 Regulates Hypoxia-Induced Angiogenesis and Cell Migration in Human Glioblastoma , 2010, Neurosurgery.
[197] B. Necela,et al. Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype , 2010, PloS one.
[198] Jean-Yves Delattre,et al. An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients , 2010, Molecular Cancer.
[199] A. Ross,et al. Cancer esearch apeutics , Targets , and Chemical Biology ecretase Inhibitors Enhance Temozolomide Treatment uman Gliomas by Inhibiting Neurosphere R opulation and Xenograft Recurrence , 2010 .
[200] Y. Rao,et al. Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells. , 2010, International journal of radiation oncology, biology, physics.
[201] Richard G Grundy,et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[202] Mark D. Johnson,et al. SNAI2/Slug promotes growth and invasion in human gliomas , 2010, BMC Cancer.
[203] Georgia Panagiotakos,et al. Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate , 2010, Stem cells.
[204] Li-ying Zhang,et al. Reduced β-catenin Expression is Associated with Good Prognosis in Astrocytoma , 2010, Pathology & Oncology Research.
[205] Jiri Zavadil,et al. Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres , 2010, Molecular Cancer.
[206] Zhiwei Wang,et al. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. , 2010, Current drug targets.
[207] Y. Bevelacqua,et al. The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit. , 2010, Genes & cancer.
[208] A. Thorburn,et al. Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity , 2010, Molecular Cancer Therapeutics.
[209] K. Nakashiro,et al. Conditional deletion of Stat3 promotes neurogenesis and inhibits astrogliogenesis in neural stem cells. , 2010, Biochemical and biophysical research communications.
[210] Y. Hitoshi,et al. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. , 2010, Cancer research.
[211] Bjørn Tore Gjertsen,et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival , 2009, Proceedings of the National Academy of Sciences.
[212] C. Holterman,et al. Human cancers converge at the HIF-2α oncogenic axis , 2009, Proceedings of the National Academy of Sciences.
[213] Julia Schüler,et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs , 2009, Nature Cell Biology.
[214] J. Myung,et al. Snail and Cox‐2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.
[215] B. Sullenger,et al. Notch Promotes Radioresistance of Glioma Stem Cells , 2009, Stem cells.
[216] Guido Nikkhah,et al. NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts , 2009, Stem cells.
[217] R. McLendon,et al. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.
[218] A. Mahadevan,et al. Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas , 2009, Neurochemistry International.
[219] D. D. Billheimer,et al. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. , 2009, The Journal of clinical investigation.
[220] H. Ford,et al. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[221] M. Katoh,et al. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. , 2009, Current molecular medicine.
[222] F. Vesuna,et al. Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells , 2009, Oncogene.
[223] Michael F. Clarke,et al. Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.
[224] Hui Wang,et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.
[225] Sabine Bahn,et al. Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia , 2009, BMC Medical Genomics.
[226] K. Camphausen,et al. Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro , 2009, Molecular Cancer Research.
[227] Simone Brabletz,et al. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer , 2009, Cancer and Metastasis Reviews.
[228] L. Denaro,et al. Hypoxia and HIF1α Repress the Differentiative Effects of BMPs in High‐Grade Glioma , 2009, Stem cells.
[229] R. Puri,et al. Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. , 2008, Neuro-oncology.
[230] Y. Komiya,et al. Wnt signal transduction pathways , 2008, Organogenesis.
[231] K. Helin,et al. A role for the transcription factor HEY1 in glioblastoma , 2008, Journal of cellular and molecular medicine.
[232] I. Pollack,et al. Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas , 2008, Journal of Neuro-Oncology.
[233] Ki Wook Kim,et al. Role of Wnt5a in the proliferation of human glioblastoma cells. , 2007, Cancer letters.
[234] R. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.
[235] Sheng-Chieh Hsu,et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. , 2007, Cancer research.
[236] T. Curran,et al. Loss of suppressor-of-fused function promotes tumorigenesis , 2007, Oncogene.
[237] M. Mullendore,et al. Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. , 2007, Endocrine-related cancer.
[238] Brian Keith,et al. Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.
[239] E. Hay,et al. TGFβ3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex , 2007, Journal of Cell Science.
[240] D. Gillespie,et al. Silencing of Hypoxia Inducible Factor-1α by RNA Interference Attenuates Human Glioma Cell Growth In vivo , 2007, Clinical Cancer Research.
[241] E. Fuchs,et al. Catenins: keeping cells from getting their signals crossed. , 2006, Developmental cell.
[242] E. Bernhard,et al. Akt1 Activation Can Augment Hypoxia-Inducible Factor-1α Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin–Independent Pathway , 2006, Molecular Cancer Research.
[243] M. Essig,et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[244] S. Donaldson,et al. Advances toward an understanding of brainstem gliomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[245] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[246] J. Massagué,et al. Smad transcription factors. , 2005, Genes & development.
[247] L. Sommer,et al. Wnt signaling: multiple functions in neural development , 2005, Cellular and Molecular Life Sciences CMLS.
[248] N. Amariglio,et al. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. , 2005, Cancer research.
[249] Mariann Bienz,et al. β-Catenin: A Pivot between Cell Adhesion and Wnt Signalling , 2005, Current Biology.
[250] A. G. de Herreros,et al. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription , 2005, The Journal of cell biology.
[251] M. Hung,et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.
[252] R. Puri,et al. Analysis of interleukin‐13 receptor α2 expression in human pediatric brain tumors , 2004, Cancer.
[253] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[254] D. Dressman,et al. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. , 2003, Cancer research.
[255] Elaine Fuchs,et al. Sticky Business Orchestrating Cellular Signals at Adherens Junctions , 2003, Cell.
[256] L. Ericson,et al. Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes , 2002, Journal of Cell Science.
[257] Eduard Batlle,et al. Snail Induction of Epithelial to Mesenchymal Transition in Tumor Cells Is Accompanied by MUC1 Repression andZEB1 Expression* , 2002, The Journal of Biological Chemistry.
[258] P. Heinrich,et al. Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited. , 2001, European journal of biochemistry.
[259] R. Puri,et al. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. , 2001, Cancer research.
[260] H. Moses,et al. Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.
[261] A. G. Herreros,et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.
[262] N. Imamoto,et al. beta-catenin can be transported into the nucleus in a Ran-unassisted manner. , 1999, Molecular biology of the cell.
[263] M. Metzker,et al. Cloning of a novel member of the low-density lipoprotein receptor family. , 1998, Gene.
[264] E R Levy,et al. Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. , 1998, Biochemical and biophysical research communications.
[265] Akira Kikuchi,et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .
[266] B. Gumbiner,et al. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of β-catenin , 1998, Current Biology.
[267] P. Adler,et al. Tissue polarity points from cells that have higher Frizzled levels towards cells that have lower Frizzled levels , 1997, Current Biology.
[268] Jörg Stappert,et al. β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .
[269] Jeremy Nathans,et al. A new member of the frizzled family from Drosophila functions as a Wingless receptor , 1996, Nature.
[270] Hugo J. Bellen,et al. Notch Signaling , 2014, Methods in Molecular Biology.
[271] M. Kieran,et al. Identification of novel biologic targets in the treatment of newly diagnosed diffuse intrinsic pontine glioma. , 2012, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[272] X. Zhi,et al. Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma by increasing hif-1alpha activity and decreasing hypoxia-associated cell death , 2012 .
[273] Lucila Ohno-Machado,et al. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. , 2011, Cancer research.
[274] K. Nakayama,et al. Loss of MKK4 expression in ovarian cancer: A potential role for the epithelial to mesenchymal transition , 2011, International journal of cancer.
[275] A. Sonabend,et al. Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133+ Glioma Stem Cells to Temozolomide Therapy , 2011, Molecular medicine.
[276] S. Eksborg,et al. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. , 2010, Cancer research.
[277] J. Uhm,et al. The transcriptional network for mesenchymal transformation of brain tumours , 2010 .
[278] H. Hoefler,et al. Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. , 2009, Frontiers in bioscience.
[279] H. Earp,et al. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. , 2008, Advances in cancer research.
[280] R. Derynck,et al. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.
[281] R. Nusse,et al. WNT targets. Repression and activation. , 1999, Trends in genetics : TIG.
[282] A. Kikuchi,et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.